Physician profile
Stuart C Marshall
NPI 1154345445
$3,422.77
in general payments reported to CMS, 2019-2025
23 companies · $48.84 in 2025
The $48.84 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,229 · 2020: $215 · 2021: $64.75 · 2022: $644 · 2023: $92.75 · 2024: $129 · 2025: $48.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $270.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $2,379.42 | 2019-2022 | |
| Orthalign INC | $210.73 | 2019 | |
| Smith+Nephew, INC. | $143.86 | 2020 | |
| Hologic Sales and Service, LLC | $68.85 | 2019-2022 | |
| Fidia Pharma USA INC. | $63.53 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $60.54 | 2023-2025 | |
| Bioventus LLC | $54.69 | 2020-2024 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Coopersurgical, INC. | $53.42 | 2021-2024 | Paragard T 380a |
| Millicent US INC | $53.26 | 2024-2025 | Intrarosa, Femring |
| Zyla Life Sciences, INC. | $49.29 | 2019 | |
| Stryker Corporation | $42.56 | 2020-2021 | |
| Abbvie INC. | $28.99 | 2022 | |
| Avion Pharmaceuticals | $26.76 | 2019-2020 | |
| Ascend Therapeutics US, LLC | $23.44 | 2024 | |
| Duchesnay USA Incorporated | $22.95 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $21.29 | 2024 | Veozah |
| Rhythm Pharmaceuticals, INC. | $21.23 | 2023 | Imcivree |
| Sanofi-Aventis U.S. LLC | $20.25 | 2023 | |
| Pacira Therapeutics, INC. | $18.75 | 2021 | |
| Depuy Synthes Sales INC. | $17.82 | 2019 | |
| Amgen INC. | $15.69 | 2019 | |
| Therapeuticsmd, INC. | $13.65 | 2019 | |
| Exeltis, USA INC. | $11.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Marshall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.